Electrophysiological Evaluation of Visual Hallucination in Parkinson’s Disease Psychosis
Objective: Our understanding of the psychosis in Parkinson’s disease (PDPsy) is incomplete, and standard of care treatment with antipsychotics has its limitations. Neuroimaging and histopathology in PDPsy reveal that visual hallucinations (VHs), the hallmark of psychosis in PDPsy, arise…Parkinson disease psychosis: A systematic review and meta-analysis
Objective: To determine the prevalence of Parkinson disease psychosis (PDP) as a function of several putative risk factors: PD duration, age, cognitive impairment, dopaminergic or…Impact of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion on Neuropsychiatric Symptoms in Clinical Practice: A Multicenter Study
Objective: To determine the incidence and risk factors of neuropsychiatric adverse events (AEs) in patients with Parkinson’s disease (PD) treated with foslevodopa/foscarbidopa continuous subcutaneous infusion…The Sweet Smell of ON: Phantosmia During Motor Fluctuations After Initiation of Foslevodopa/Foscarbidopa Infusion Therapy
Objective: To report a unique case of phantosmia/olfactory hallucinations (OfH) emerging as a non-motor fluctuation after initiation of foslevodopa/foscarbidopa (LDp/CDp) infusion at a lower levodopa…Impact of Amyloid-beta co-pathology on future hallucination in Parkinson’s disease
Objective: To investigate whether baseline amyloid-β positivity is associated with subsequent development of major hallucination in Parkinson’s disease (PD). Background: Hallucinations are a major non-motor complication…Drug-Induced Movement Disorders in Elderly Patients with Dementia: A Case Study of Acute Dystonia Following Third-Generation Antipsychotic Use
Objective: To represent a case of acute dystonic dyskinesias after breхpiprazole use by the patient with frontotemporal dementia (behavioral variant) Background: Drug-induced movement disorders (DIMDs)…Virtual Reality to Assess for Digital Biomarkers of Visual Hallucinations in Parkinson’s Disease
Objective: Use a novel virtual reality (VR) protocol to evaluate for potential digital biomarkers of visual hallucinations (VH) in Parkinson’s Disease (PD). Background: VH are common…Auditory Musical Hallucinations in Parkinson’s disease: A Case Series
Objective: To report a series of twelve patients with Parkinson’s disease (PD) who experienced auditory musical hallucinations (AMH). Background: Hallucinations occur in 20-40% of patients…Neural Signatures of Hallucination Emergence in Dementia with Lewy Bodies
Objective: REM sleep behavior disorder (RBD) is a prodromal state for alpha-synucleinopathy. Here, we present a behavioral marker for hallucination propensity that distinguishes Dementia with…Prodromal Lewy body dementia features in isolated REM sleep behavior disorder with neuronal synuclein disease
Objective: To assess for cognitive impairment and features of prodromal Lewy body dementia (LBD) in persons with isolated REM sleep behavior disorder (iRBD) and neuronal…
- 1
- 2
- 3
- …
- 11
- Next Page »